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Background
The benefits from treatment with antivenom sera are
indubitable. However, the mechanism for toxin neutrali-
zation has not been completely elucidated. A mixture of
anti-bothropic and anti-crotalic horse antivenom has
been reported to be more effective in neutralizing the
effects of B. jararacussu snake venom than anti-bothropic
antivenom alone. This study determined which regions in
the three PLA2s from B.jararacussu snake venom are
bound by antibodies in tetravalent anti-bothropic and
monovalent anti-crotalic commercial horse antivenom.
Methods
The epitopes recognized by therapeutic horse antivenom
sera in the three major PLA2s present in the venom of
B. jararacussu, BthTX-I, BthTX-II and BthA-I, were
mapped using the parallel Spot-synthesis strategy. Two
peptide libraries were designed to more precisely define
the epitopes recognized by anti-bothropic and/or anti-
crotalic horse antivenom. Each consisted of 69 peptide
sequences of fourteen amino acids each that overlapped
by nine amino acids and covered the entire protein
sequences of the three PLA2s. The oligomeric structure
of PLA2S proteins were solved by X-ray crystallography
and are available in the protein data bank. The
sequences of fifty PLA2s were selected and grouped into
three sub-groups. Shared amino acids sequence from
the 12 epitopes recognized by the reaction between the
B. jararacussu PLA2s and anti-crotalic/anti-bothropic
horse antivenom were analyzed by a multiple sequence
alignment.
Results and conclusions
Mapping experiments of BthTX-I, BthTX-II and BthA-I
using two small libraries of 69 peptides each revealed
six major IgG-binding epitopes that were recognized by
both anti-bothropic and anti-crotalic horse antivenom.
Two epitopes in BthTX-I were only recognized by the
anti-bothropic horse antivenom, while anti-crotalic horse
antivenom recognized four unique epitopes across the
three PLA2s. Our studies suggest that the harmful activ-
ities of the PLA2s present in the venom of B. jararacussu
are neutralized by the combinatorial treatment with both
antivenom sera through their complementary binding
sites, which provides a wide coverage on the PLA2s. In
conclusion, the peptide arrays formed directly onto cellu-
lose membranes allowed the identification of the major
antigenic determinants in the three most important
PLA2s (BthTX-I, BthTX-II and BthA-I) isolated from B.
jararacussu snake venom recognized by commercial anti-
bothropic and anti-crotalic horse antivenom. The cross-
reactive epitopes located in the Lys49-PLA2, the major
protein of this venom, recognized two specific epitopes
located in a region of the enzyme responsible for the
myotoxic action, which contributes to the deleterious
effects of snake venom. In addition, the ability of the
anti-crotalic horse antivenom to neutralize the anticoagu-
lant activity was most likely associated with the acidic
Asp49-PLA2. This study provides proof that the mixture
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qualitatively more effective in neutralizing the effects
unleashed of B. jararacussu snakebite. Regions recognized
by the protective antivenom sera are prime candidates for
improved venom cocktails or a chimeric protein encoding
the multiple epitopes to immunize animals as well as for
designing future synthetic vaccines.
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